Diagnosis and management of patients suffering from non-alcoholic fatty liver disease;Diagnostika a manažment pacientov s nealkoholovou tukovou chorobou pečene

Ceska a Slovenska Gastroenterologie a Hepatologie

Volumn 61, Issue 2, 2007, Pages 96-102

  Koller, Tomáš ^a  

^a V Interna Klinika LF UK a FNsP   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954292317     PISSN: 1213323X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. AGA technical review on Nonalcoholic Fatty Liver Disease. Gastroenterology 2002; 123:1705-1725. (Pubitemid 35231670)
2. Holomáň J, Glasa J. (eds.) Non-alcoholic steatohepatitis. Progress in Hepato-Pharmacology 2001; 6: 61.
3. Krahulec B. Odporúčania pre liečbu obezity u dospelých. Európsky projekt primárnej starostlivosti a odporúčania Obezitologickej sekcie Slovenskej diabetologickej spoločnosti. Diabetes Obez 2004; 4: 91-97.
4. Larrey D. Stéatohepatite non-alcoolique: histoire naturelle et diagnostic. Gastroenterol Clin Biol 2003; 27: 793-795.
5. Brunt EM. Nonalcoholic Steatohepatitis. Sem Liv Dis 2004; 24: 3-20.
6. Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study o 103 patients with sequential liver biopsies. J Hepatol 2005; 42: 132-138. (Pubitemid 40038911)
7. Day CP. Non-alcoholic fatty liver disease, Evidence Based Gastroenterology BMJ Publishing 2004; 393-403.
8. Guha IN, Parkers J, Roderick PR, et al. Non-invasive markers assotiated with liver fibrosis in non-alcoholic fatty liver disease. Gut 2006; 55: 1650-1660. (Pubitemid 44629217)
9. Dixon JB, Bhathal PS, Hughes NR, et al. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology 2004; 39: 1647-1654.
10. Ramesh S, Sanyal AJ. Evaluation and management of non-alcoholic steatohepatitis. J Hepatol 2005; 42: S2-S12.
11. Ueno T, Sugawara H, Sujaku K, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997; 27: 103-107. (Pubitemid 27357062)
12. Uygun A, Kadayifci A, Isik AT, et al. Metformin in the treatment of patients with non alcoholic steatohepatitis. Aliment Pharmacol Ther 2004; 19: 537-544. (Pubitemid 38387180)
13. Browning JD. Statins and hepatic steatosis: perspectives from the Dallas Heart Study. Hepatology 2006; 44: 466-471.
14. Yokohama S, Yoneda M, Haneda M, et al. Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis. Hepatology 2004; 40: 1222-1225. (Pubitemid 39425579)
15. Lindor KD, Kowdley KV, Heathcote EJ, et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 2004; 39: 770-778. (Pubitemid 38337657)
16. Harrison S, Torgerson S, Hayashi P. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003; 98: 2485-2490. (Pubitemid 37448761)